Oruka Therapeutics Inc (NASDAQ:ORKA)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting 0.62. At the close of trading, the stock’s price was $11.40, to imply a decrease of -12.84% or -$1.68 in intraday trading. The ORKA share’s 52-week high remains $33.00, putting it -189.47% down since that peak but still an impressive 11.14% since price per share fell to its 52-week low of $10.13. The company has a valuation of $398.98M, with an average of 0.2 million shares in intraday trading volume over the past 10 days and average of 298.63K shares over the past 3 months.

Oruka Therapeutics Inc (NASDAQ:ORKA) trade information

After registering a -12.84% downside in the last session, Oruka Therapeutics Inc (ORKA) has traded red over the past five days. The 5-day price performance for the stock is -15.24%, and -39.97% over 30 days. With these gigs, the year-to-date price performance is -41.21%.

The extremes give us $20 and $40 for target low and target high price respectively. As such, ORKA has been trading -250.88% off suggested target high and -75.44% from its likely low.

ORKA Dividends

Oruka Therapeutics Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

We also have Fidelity Select Portfolios – Health Care and Fidelity Advisor Health Care Fund as the top two Mutual Funds with the largest holdings of the Oruka Therapeutics Inc (ORKA) shares. Going by data provided on Nov 30, 2024 , Fidelity Select Portfolios – Health Care holds roughly 889.35 shares. This is just over 2.54% of the total shares, with a market valuation of $10.14 million. Data from the same date shows that the other fund manager holds a little less at 561.71, or 1.60% of the shares, all valued at about 6.4 million.